Fleury S.A. - Asset Resilience Ratio

Latest as of December 2025: 16.19%

Fleury S.A. (FLRY3) has an Asset Resilience Ratio of 16.19% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Fleury S.A. (FLRY3) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

R$2.14 Billion

≈ $420.03 Million USD Cash + Short-term Investments

Total Assets

R$13.22 Billion

≈ $2.59 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Fleury S.A.'s Asset Resilience Ratio has changed over time. See what is Fleury S.A.'s book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Fleury S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Fleury S.A. stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	R$0.00	0%
Short-term Investments	R$2.14 Billion	16.19%
Total Liquid Assets	R$2.14 Billion	16.19%

Asset Resilience Insights

Good Liquidity Position: Fleury S.A. maintains a healthy 16.19% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Fleury S.A. Industry Peers by Asset Resilience Ratio

Compare Fleury S.A.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Eurofins-Cerep SA PA:ALECR	Diagnostics & Research	6.56%
Inoviq Ltd AU:IIQ	Diagnostics & Research	56.29%
Bcal Diagnostics Ltd AU:BDX	Diagnostics & Research	0.00%
Imagion Biosystems Ltd AU:IBX	Diagnostics & Research	150.16%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for Fleury S.A. (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Fleury S.A..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	16.19%	R$2.14 Billion ≈ $420.03 Million	R$13.22 Billion ≈ $2.59 Billion	-1.57pp
2024-12-31	17.76%	R$2.32 Billion ≈ $455.22 Million	R$13.06 Billion ≈ $2.56 Billion	+9.97pp
2023-12-31	7.79%	R$902.21 Million ≈ $177.03 Million	R$11.58 Billion ≈ $2.27 Billion	-8.79pp
2022-12-31	16.58%	R$1.29 Billion ≈ $253.56 Million	R$7.79 Billion ≈ $1.53 Billion	+3.92pp
2021-12-31	12.67%	R$769.39 Million ≈ $150.97 Million	R$6.07 Billion ≈ $1.19 Billion	-5.78pp
2020-12-31	18.45%	R$1.02 Billion ≈ $199.61 Million	R$5.51 Billion ≈ $1.08 Billion	+2.83pp
2019-12-31	15.62%	R$795.89 Million ≈ $156.17 Million	R$5.10 Billion ≈ $1.00 Billion	-4.96pp
2018-12-31	20.57%	R$804.49 Million ≈ $157.85 Million	R$3.91 Billion ≈ $767.30 Million	+1.56pp
2017-12-31	19.01%	R$670.57 Million ≈ $131.58 Million	R$3.53 Billion ≈ $692.13 Million	+5.59pp
2016-12-31	13.42%	R$403.47 Million ≈ $79.17 Million	R$3.01 Billion ≈ $589.80 Million	+13.28pp
2015-12-31	0.15%	R$4.70 Million ≈ $922.81K	R$3.20 Billion ≈ $628.73 Million	+1.13pp
2014-12-31	-0.98%	R$-31.46 Million ≈ $-6.17 Million	R$3.21 Billion ≈ $629.81 Million	-0.58pp
2013-12-31	-0.40%	R$-12.97 Million ≈ $-2.54 Million	R$3.21 Billion ≈ $630.09 Million	-0.01pp
2012-12-31	-0.40%	R$-10.86 Million ≈ $-2.13 Million	R$2.74 Billion ≈ $537.28 Million	-0.41pp
2011-12-31	0.02%	R$434.00K ≈ $85.16K	R$2.83 Billion ≈ $555.63 Million	+0.01pp
2010-12-31	0.00%	R$19.00K ≈ $3.73K	R$1.33 Billion ≈ $260.61 Million	+1.36pp
2009-12-31	-1.36%	R$-17.07 Million ≈ $-3.35 Million	R$1.26 Billion ≈ $246.48 Million	+2.93pp
2008-12-31	-4.29%	R$-26.44 Million ≈ $-5.19 Million	R$616.76 Million ≈ $121.02 Million	-2.36pp
2007-12-31	-1.93%	R$-9.75 Million ≈ $-1.91 Million	R$505.94 Million ≈ $99.27 Million	+5.58pp
2006-12-31	-7.51%	R$-24.48 Million ≈ $-4.80 Million	R$326.11 Million ≈ $63.99 Million	--

pp = percentage points

About Fleury S.A.

SA:FLRY3 Brazil Diagnostics & Research

Market Cap

$1.72 Billion

R$8.78 Billion BRL

Market Cap Rank

#6816 Global

#71 in Brazil

Share Price

R$16.08

Change (1 day)

+0.31%

52-Week Range

R$12.46 - R$17.95

All Time High

R$26.18